Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.
about
Human parvovirus B19.Human Parvovirus B19 and blood product safety: a tale of twenty years of improvementsProductive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFαThe structure of human parvovirus B19Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cellsThe globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalizationParvovirus B19 - Revised.Gangliosides are essential for bovine adeno-associated virus entry.Parvovirus vectors for cancer gene therapy.Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor.Parvovirus B-19 infection during pregnancy.Pathways of cell infection by parvoviruses and adeno-associated virusesParvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor CellsHuman parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria.Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replicationClinical aspects of parvovirus B19 infection.Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.Human Parvoviruses.Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.Pharmacological activation of guanine nucleotide exchange factors for the small GTPase Rap1 recruits high-affinity beta1 integrins as coreceptors for parvovirus B19: improved ex vivo gene transfer to human erythroid progenitor cells.Dietary phenolic acids act as effective antioxidants in membrane models and in cultured cells, exhibiting proapoptotic effects in leukaemia cellsCharacterization of the early steps of human parvovirus B19 infection.Parvovirus B19 integration into human CD36+ erythroid progenitor cells.The Epimmunity Theory: The Single Cell Defenses against Infectious and Genetic Diseases.DNA Binding and Cleavage by the Human Parvovirus B19 NS1 Nuclease Domain.CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells.Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.Recent Advances in Replication and Infection of Human Parvovirus B19.Parvovirus B19 Achievements and Challenges
P2860
Q24532891-FB7B8261-1B5E-4F66-B1B9-66DDB1E138D3Q28087734-65FD9166-781E-47C6-9727-77E512FB4046Q28478598-3ADEE4BE-11AA-4AF9-A449-81B4EA4DCC2DQ30163895-DE77DCC1-A855-453B-AE1D-468CE3A9A702Q33900233-E72DC9E4-03F3-45DA-9380-204DA5230E99Q34291034-825C42BD-632D-4802-85A3-CB5C8320DD34Q34623255-AFED4A34-A6F6-40D0-88D4-451945254B5BQ34625443-B90993AF-A943-4924-89A8-E4070B588927Q34648299-CA013CE5-C21D-4D87-9CD3-30BF784C8480Q35609780-8D356352-88B0-4692-9487-3581B10F017EQ35614588-594CB6D5-F957-4CA6-A20A-D6EDFFE65056Q35691814-8619DA9A-6266-4AAD-9A92-D84757DB92ECQ35803571-32487D7E-C2A5-4ED6-82B1-231A5DFF0618Q35914623-4C2A1ADA-1314-4D23-A48D-E663F27AEAF9Q36326300-5CF3B5D6-EED8-4678-AC2D-B10024FD4424Q36405378-410CAC99-E805-4528-AF99-0E7241363601Q36483931-D08B3A85-DE76-459E-9E73-E60705724B0CQ36589340-89A155C6-57CA-40F6-B589-6DEB634F4A1FQ37336824-B4BE3E5F-1065-472B-9930-239DFE4C7CE0Q37378794-8FE82E6D-1400-41F6-B072-A72D8A3CECA8Q38895571-6BB96195-A171-4FD7-85E1-9893C4C81689Q38996997-224CE864-4B21-4B6B-B7E1-111BA018D5D9Q39139921-F1CFB486-E9E2-4EA6-96E4-1361930CBD75Q39309590-EB99D520-C0C1-4794-B43C-5EC55FDF3E90Q39315093-3AA26CF0-94C6-4D2F-AF7E-B1EA0EA4AA4BQ39327644-A5068280-DF73-4B82-9258-BCF7E22C1E1EQ40083769-2C734BA1-7C58-439A-8475-3CB81EBBA16EQ40154111-6CEF4756-1174-4EEF-9CD6-49BDE5E2ACB8Q40465741-1FB01B12-030B-486D-8BDF-B2D4DEBD1EC7Q40907249-4413A1F0-EA13-4E86-AC68-9BF94C9FB2F4Q42006546-58172C59-2B5B-4D7B-AD6C-6411A31F18EBQ46319662-852FB642-62C3-4D63-ADA1-9C4FF749FB08Q51700765-0B612DDA-4417-4AD1-9981-08E0F253D44FQ55236939-D69343DA-F98B-4666-A4E5-42FDAFFED7E5Q58666387-31716790-E8BE-49A5-9772-10D7BFD08BF4
P2860
Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Recombinant human parvovirus B ...... of human hematopoietic cells.
@ast
Recombinant human parvovirus B ...... of human hematopoietic cells.
@en
type
label
Recombinant human parvovirus B ...... of human hematopoietic cells.
@ast
Recombinant human parvovirus B ...... of human hematopoietic cells.
@en
prefLabel
Recombinant human parvovirus B ...... of human hematopoietic cells.
@ast
Recombinant human parvovirus B ...... of human hematopoietic cells.
@en
P2093
P2860
P1433
P1476
Recombinant human parvovirus B ...... of human hematopoietic cells.
@en
P2093
A Srivastava
K A Weigel-Kelley
P2860
P304
P356
10.1128/JVI.75.9.4110-4116.2001
P577
2001-05-01T00:00:00Z